Subbarao, Kanta
The University of Melbourne · Peter Doherty Institute
12 papers on CoChatORCID 0000-0003-1713-3056
Most cited papers
- Verified
What level of neutralising antibody protects from COVID-19?
Khoury, D. S., Cromer, D., Reynaldi, A., Schlub, T. E., Wheatley, A. K., Juno, J. A., Subbarao, K., Kent, S. J., Triccas, J. A., & Davenport, M. P. (2021) · Nature Medicine
SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies
Cited by 3,742
- Verified
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
Khoury, D. S., Cromer, D., Reynaldi, A., Schlub, T. E., Wheatley, A. K., Juno, J. A., Subbarao, K., Kent, S. J., Triccas, J. A., & Davenport, M. P. (2021) · Nature Medicine
SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies
Cited by 3,742
- Verified
An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus
Traggiai, E., Becker, S., Subbarao, K., Kolesnikova, L., Uematsu, Y., Gismondo, M. R., Murphy, B. R., Rappuoli, R., & Lanzavecchia, A. (2004) · Nature Medicine
SARS-CoV-2 and COVID-19 ResearchMonoclonal and Polyclonal Antibodies Research
Cited by 697
- Verified
Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19
Juno, J. A., Tan, H.-X., Lee, W. S., Reynaldi, A., Kelly, H. G., Wragg, K., Esterbauer, R., Kent, H. E., Batten, C. J., Mordant, F. L., et al. (2020) · Nature Medicine
SARS-CoV-2 and COVID-19 ResearchT-cell and B-cell Immunology
Cited by 437
- Verified
Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19
Wheatley, A. K., Juno, J. A., Wang, J. J., Selva, K. J., Reynaldi, A., Tan, H.-X., Lee, W. S., Wragg, K. M., Kelly, H. G., Esterbauer, R., et al. (2021) · Nature Communications
SARS-CoV-2 and COVID-19 ResearchImmune responses and vaccinations
Cited by 351
- Verified
Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses
Joyce, M. G., Wheatley, A. K., Thomas, P. V., Chuang, G.-Y., Soto, C., Bailer, R. T., Druz, A., Georgiev, I. S., Gillespie, R. A., Kanekiyo, M., et al. (2016) · Cell
Influenza Virus Research Studiesvaccines and immunoinformatics approaches
Cited by 333
- Verified
Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection
Henry Dunand, C. J., Leon, P. E., Huang, M., Choi, A., Chromikova, V., Ho, I. Y., Tan, G. S., Cruz, J., Hirsh, A., Zheng, N.-Y., et al. (2016) · Cell Host & Microbe
Influenza Virus Research StudiesMonoclonal and Polyclonal Antibodies Research
Cited by 268
- Verified
SARS-CoV Pathogenesis Is Regulated by a STAT1 Dependent but a Type I, II and III Interferon Receptor Independent Mechanism
Frieman, M. B., Chen, J., Morrison, T. E., Whitmore, A., Funkhouser, W., Ward, J. M., Lamirande, E. W., Roberts, A., Heise, M., Subbarao, K., et al. (2010) · PLoS Pathogens
SARS-CoV-2 and COVID-19 Researchinterferon and immune responses
Cited by 158
- Verified
Consensus summary report for CEPI/BC March 12–13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines
Lambert, P.-H., Ambrosino, D. M., Andersen, S. R., Baric, R. S., Black, S. B., Chen, R. T., Dekker, C. L., Didierlaurent, A. M., Graham, B. S., Martin, S. D., et al. (2020) · Vaccine
SARS-CoV-2 and COVID-19 ResearchImmune responses and vaccinations
Cited by 119
- Verified
Measuring immunity to SARS-CoV-2 infection: comparing assays and animal models
Khoury, D. S., Wheatley, A. K., Ramuta, M. D., Reynaldi, A., Cromer, D., Subbarao, K., O’Connor, D. H., Kent, S. J., & Davenport, M. P. (2020) · Nature Reviews Immunology
SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections Studies
Cited by 115
- Verified
Evaluation of the attenuation, immunogenicity, and efficacy of a live virus vaccine generated by codon-pair bias de-optimization of the 2009 pandemic H1N1 influenza virus, in ferrets
Broadbent, A. J., Santos, C. P., Anafu, A., Wimmer, E., Mueller, S., & Subbarao, K. (2016) · Vaccine
Influenza Virus Research StudiesVirology and Viral Diseases
Cited by 79
- Verified
Antibody pressure by a human monoclonal antibody targeting the 2009 pandemic H1N1 virus hemagglutinin drives the emergence of a virus with increased virulence in mice
O’Donnell, C. D., Vogel, L., Wright, A., Das, S. R., Wrammert, J., Li, G.-M., McCausland, M., Zheng, N.-Y., Yewdell, J. W., Ahmed, R., et al. (2012) · mBio
Influenza Virus Research StudiesEvolution and Genetic Dynamics
Cited by 77
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free